SCHEMBL4969119

SCHEMBL4969119

Cc1ccc(S(=O)(=O)OC(OS(=O)(=O)c2ccc(C)cc2)C(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.46
VDR P11473 1/20 0.46
CA2 P00918 6/20 0.43
CA1 P00915 5/20 0.43
CA9 Q16790 4/20 0.43
CA12 O43570 3/20 0.43
CA7 P43166 2/20 0.43
CA3 P07451 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
TLR9 Q9NR96 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
GBA1 P04062 1/20 0.40
MMP9 P14780 2/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629581 0.86 TLR9 (0.48) GAAVDRCA2CA1CA9
SCHEMBL2342945 0.85 GAA (0.52) GAAVDRCA2CA1CA9
SCHEMBL5557903 0.85 GAA (0.52) GAAVDRCA2CA1CA9
SCHEMBL14779220 0.84 GAA (0.46) GAAVDRCA2CA1CA9
SCHEMBL143705 0.83 GAA (0.50) GAAVDRCA2CA1CA9
SCHEMBL890642 0.83 GAA (0.50) GAAVDRCA2CA1CA9
Ammonia Solution, Strong SCHEMBL5917791 0.82 GAA (0.48) GAAVDRCA2CA1CA9
SCHEMBL19949926 0.82 GAA (0.48) GAAVDRCA2CA1CA9
SCHEMBL14778368 0.82 TLR9 (0.48) GAAVDRCA2CA1CA9
SCHEMBL2555662 0.82 GAA (0.48) GAAVDRCA2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971598-A1 BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2008-09-24 EP disclosed
WO-2007061670-A1 BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2007-05-31 WO disclosed